Jisce R. Puik

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancer.

Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 19, 2026

Prostate-specific membrane antigen as target for vasculature-directed therapeutic strategies in solid tumors.

Prostate-specific membrane antigen as target for vasculature-directed therapeutic strategies in solid tumors.

Journal: Critical reviews in oncology/hematology

Published: July 19, 2024

18F-Prostate-Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN-2): a phase I/II study.

18F-Prostate-Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN-2): a phase I/II study.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: March 07, 2024

Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma.

Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 27, 2024

Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer.

Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer.

Journal: The journal of liquid biopsy

Published: February 20, 2024

MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort study.

MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort study.

Journal: International journal of surgery (London, England)

Published: February 15, 2024

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.

Journal: Experimental hematology & oncology

Published: September 13, 2023

Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.

Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.

Journal: JAMA network open

Published: August 28, 2023

Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study.

Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study.

Journal: Frontiers in pharmacology

Published: August 09, 2023

hENT1 as a Predictive Biomarker in PDAC-Letter.

hENT1 as a Predictive Biomarker in PDAC-Letter.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 13, 2022

Novel Strategies to Address Critical Challenges in Pancreatic Cancer.

Novel Strategies to Address Critical Challenges in Pancreatic Cancer.

Journal: Cancers

Published: August 19, 2022

Factors that influence the pancreatic and duodenal microbiome in patients undergoing pancreatic surgery.

Factors that influence the pancreatic and duodenal microbiome in patients undergoing pancreatic surgery.

Journal: PloS one

Published: June 26, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026